Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001641172-25-003828
Filing Date
2025-04-11
Accepted
2025-04-11 16:15:29
Documents
1
Effectiveness Date
2025-04-11
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 9047
  Complete submission text file 0001641172-25-003828.txt   10540
Mailing Address 10531 4S COMMONS DRIVE SUITE 166-550 SAN DIEGO CA 92127
Business Address 1035 CAMBRIDGE STREET SUITE 18A CAMBRIDGE MA 02141 (617) 798-6700
Ernexa Therapeutics Inc. (Filer) CIK: 0000748592 (see all company filings)

EIN.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-543509 | Film No.: 25832270
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)